Citigroup (C)
(Delayed Data from NYSE)
$63.71 USD
-0.46 (-0.72%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $63.72 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$63.71 USD
-0.46 (-0.72%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $63.72 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Zacks News
Pre-Markets in the Green Ahead of Inflation Data Release
by Zacks Equity Research
Pre-Markets in the Green Ahead of Inflation Data Release
Pre-Markets Bounce Back Ahead of Big Data: CPI, Q3 Earnings
by Mark Vickery
On Thursday and Friday of this week, we'll see Consumer Price Index (CPI) and Producer Price Index (PPI) figures out for September.
Analysts Estimate Citigroup (C) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Citigroup (C) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Citigroup (C) Stock Moves -0.06%: What You Should Know
by Zacks Equity Research
In the most recent trading session, Citigroup (C) closed at $62.60, indicating a -0.06% shift from the previous trading day.
U.S. Senator Urges OCC to Impose Growth Limitations on Citigroup
by Zacks Equity Research
Senator Warren insists U.S. regulators to impose growth cap on C, citing its persisting regulatory issues and claiming that the bank has become too big to manage.
Should JPMorgan Stock be Part of Your Portfolio Ahead of Q3 Earnings?
by Zacks Equity Research
JPM is slated to report Q3 earnings next week. Here, we discuss the factors influencing its performance and whether the stock should be in your portfolio.
The Zacks Analyst Blog Highlights BNY Mellon, M&T Bank, Citigroup, JPMorgan and Fifth Third Bank
by Zacks Equity Research
BNY Mellon, M&T Bank, Citigroup, JPMorgan and Fifth Third Bank are included in this Analyst Blog.
S&P 500 Banks Outperform the Index YTD: 5 Stocks to Watch
by Riya Anand
Stocks like BK, MTB, C, JPM and FITB have outperformed the S&P 500 index in the year-to-date period, owing to the optimism surrounding the Fed interest rate cut
JPMorgan Enters Collaborations to Broaden Reach in Private Credit
by Zacks Equity Research
JPM agrees to partner with Cliffwater, FS Investments and Shenkman Capital to boost its reach into the $1.7-trillion private credit market.
Citigroup's 2013 AML Enforcement Action Terminated by Federal Reserve
by Zacks Equity Research
The enforcement action against C from 2013, which addressed flaws in the bank and its subsidiaries' AML practices, is officially terminated by the Fed.
The Zacks Analyst Blog Highlights NIO, Tesla and Citigroup
by Zacks Equity Research
NIO, Tesla and Citigroup are included in this Analyst Blog.
Under $10 NIO Stock Surges With New Capital - Should You Buy?
by Tirthankar Chakraborty
With NIO's growth potential boosted by new cash investment, stimulus measures, and demand for new models, is it a good time to buy?
How to Play BAC Stock Amid Interest Rate Cuts & Branch Expansion Plan?
by Swayta Shah
Lower interest rates and branch expansion efforts are likely to aid Bank of America. Let's decipher how BAC is likely to perform amid such a backdrop.
Citigroup (C) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the most recent trading session, Citigroup (C) closed at $62.60, indicating a +1.18% shift from the previous trading day.
BNY Mellon Receives SEC's Approval to Offer ETF Crypto Custody Service
by Zacks Equity Research
BK obtains SEC's approval to expand into bitcoin and ether ETFs and offer crypto-custody services to tap into the sector growth.
Citigroup Inks Deal to Form Private Credit Program With Apollo
by Zacks Equity Research
C enters into an agreement with APO to form a $25 billion private credit, direct lending program.
Will JPM, C and Others Follow JEF and Post Solid Q3 IB Income?
by Swayta Shah
Jefferies post robust Q3 IB fee growth. Let's try to figure out how other banks, including JPMorgan, Citigroup, Bank of America and Goldman, will likely perform.
Investors Heavily Search Citigroup Inc. (C): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Citigroup (C). This makes it worthwhile to examine what the stock has in store.
Should Investors Keep Citigroup Stock on Radar Post Fed Rate Cut?
by Riya Anand
C's financials are expected to benefit from the Fed rate cuts over the long term. Yet, ongoing legal scrutiny and rising credit losses are worrisome.
Is JPMorgan the Best Investment Bet Among Big Bank Stocks Right Now?
by Swayta Shah
Does JPM's leadership position in several businesses, the largest branch network in the U.S., and solid prospects make it the best pick now? Let's find out.
5 Reasons Why 2025 Will See a Nuclear Energy Revival
by Andrew Rocco
Nuclear energy is the cleanest and most affordable energy source. Despite suffering a reputational hit in the 1980s, there are signs that nuclear will power the next global energy revolution.
Citigroup (C) Laps the Stock Market: Here's Why
by Zacks Equity Research
Citigroup (C) reachead $62.58 at the closing of the latest trading day, reflecting a +0.71% change compared to its last close.
Citigroup's China Expansion Plans Stalled Amid Regulatory Probes
by Zacks Equity Research
C's efforts to expand into China are held up by the U.S. regulators following a Fed's penalty related to its data and management risk controls.
Navient Finalizes Divesture of Healthcare Services Arm to CorroHealth
by Zacks Equity Research
NAVI to divest its healthcare services business Xtend to CorroHealth. Over 925 Xtend employees join the CorroHealth team as part of the deal.
HSBC to Divest German Private Banking Business to BNP Paribas
by Zacks Equity Research
HSBC announces an agreement to sell its Germany-based private banking business to BNPQY. This is part of its plan to focus on the Asia region.